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Dr Allen Hamdan (Boston, Mass). I think you bring up a
really crucial set of data here that we need to all look at, especially
as this becomes a more common situation. I am just going to go
right to some of the questions for the interest of time.
Have you looked at follow-up duplex—3, 6 months, a year
down the line—in these patients, and do these PSVs [peak systolic
velocities] persist over time, or is this just something you see early?
You didn’t mention anything on, or at least I didn’t see in the
paper, on recurrent stenosis. So was there a disproportionate
number of patients who had recurrent stenosis that maybe got
closed cells or open cells and that could have affected your data?
As a corollary, are there any other anatomic criteria that you
found, either on CTAs [computed tomography angiographies] or
angiograms that could have predicted, potentially, these changes?
And finally, have you looked at any of the published clinical
trials and looked at trials that had a higher proportion of closed-cell
stents, and in those trials is there a higher in-stent restenosis quoted
that maybe is a false elevation?
DrDamon S. Pierce. In answer, in brief, I think a few of your
questions dovetail into one, and that is that the data we have
presented were derived from immediate postintervention duplex
scans and we do not have a substantial follow-up data at this point.
That is what we plan to do, to see if these elevations and the
discrepancies persist through follow-up duplex examinations.
I don’t have any specific published reports that I can cite that
demonstrate disproportionality between closed- and open-cell
stents as you mention in regard to in-stent restenosis.
And no, we did not find any anatomic criteria for recurrent
stenosis.
Dr Massoud Alipour (Newport Beach, Calif). I’m a cardiol-
ogist and vascular technologist. I do hands-on studies. This is a fact
well known in the last, at least 4, 5 years, that intrastent velocity
increases because of very low compliance of the stent; therefore,
your systolic velocity is expected to rise and your diastolic velocity
is expected to decrease, not increase, because there is no reboundWhat you really considered false-positive, all of them are
true-negative. This shouldn’t be considered false-positive, because
even the criteria that you are using are very loose criteria. The
ICA/CCA [internal carotid artery/common carotid artery] veloc-
ity ratio of 1.7 is not significant at all. It should be considered
true-negative. And what you have mentioned about velocity of 125
normal and velocity ratio of 2, this should be consideredhemodynam-
ically not significant at all. So what you are mentioning as false-
positive, I believe, again, is true-negative and is quite expected.
Dr Pierce. That was not the aim of our study. The aim of our
study was to compare stent design differences in carotid velocities,
not in regard to the frequency of abnormal duplexes. We under-
stand that changes in elastic modulus generated by different stent
designs alter the compliance of the carotid artery after stenting.
What is significant in our data is the difference in carotid velocities
and the increased odds ratio of a closed-cell stents to yield abnor-
mal duplex velocities after carotid stenting.
Dr Jeffrey Hsu (Fontana, Calif). I just have a quick question
for you. First, a comment: We have also noticed an elevation of
velocities in our stents and we have been following our patients
with duplex. We have now changed our practice to get a postop-
erative duplex, basically prior to discharge, based on the assump-
tion that we are going to need some sort of baseline to compare to,
rather than to bring them back 6 to 8 weeks later, or 3 months or
other interval. So the question is, is a postprocedure ultrasound
before discharge something you recommend?
Dr Pierce. Well, it is tough to say based on these data, and I
think we will have more of an answer when we follow this subset of
patients to see if these elevations in velocities persist. But I think it
may be a good piece of data to have a baseline duplex before a
patient leaves the hospital.
Dr Martin Back (Tampa, Fla). Balloon size is going to
influence the residual diameter after angioplasty of stented stenoses
and therefore the postprocedural velocities. You need to make sure
that the balloon sizes that were used in your cases were equivalent
in those two groups for residual velocities to not differ.
